MFDS — authorised 30 July 2018
- Marketing authorisation holder: ACCORD HLTHCARE
- Status: likely_approved
🇰🇷 Torisel in South Korea
MFDS authorised Torisel on 30 July 2018
Marketing authorisations
MFDS — authorised 16 August 2019
- Marketing authorisation holder: GLAND
- Status: likely_approved
Torisel in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in South Korea
Frequently asked questions
Is Torisel approved in South Korea?
Yes. MFDS authorised it on 30 July 2018; MFDS authorised it on 16 August 2019.
Who is the marketing authorisation holder for Torisel in South Korea?
ACCORD HLTHCARE holds the South Korean marketing authorisation.